🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yingxin He

Southwest University of Science and Technology

ORCID: 0000-0003-2543-4553

Also affiliated with Sun Yat-sen University, Washington University in St. Louis, China Academy of Engineering Physics, Sun Yat-sen University Cancer Center, New York University

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease”.

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease

Nature Aging(2023)10.1038/s43587-023-00380-7
N/A
0.757DataRank · unranked
154 citations

Benjamin Saef, Yan Li, Brian A. Gordon, Yingxin He, Kanta Horie +14 more

Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease

Nature Medicine(2025)10.1038/s41591-025-03617-7
N/A
0.697DataRank · unranked
103 citations

Gemma Salvadó, Rama K. Koppisetti, Shorena Janelidze, Nicolas R. Barthélemy, Yingxin He +14 more

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

Nature Medicine(2022)10.1038/s41591-022-02075-9
N/A
0.686DataRank · unranked
96 citations

Nicolas R. Barthélemy, Salvatore Spina, Lawren VandeVrede, Yingxin He, Ross W. Paterson +17 more

A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease

Brain Communications(2022)10.1093/braincomms/fcac045
N/A
0.606DataRank · unranked
56 citations

Yingxin He, Nicolas R. Barthélemy, Hong Jiang, Yan Li, Ethan Park +5 more

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease

Neurotherapeutics(2025)10.1016/j.neurot.2025.e00591
N/A
0.548DataRank · unranked
13 citations

Juan Pablo Palavicini, Justin Melendez, Nicolas R. Barthélemy, Yingxin He, Tiffany F. Kautz +22 more

Predicting continuous amyloid PET values with CSF tau phosphorylation occupancies

Alzheimer s & Dementia(2024)10.1002/alz.14132
N/A
0.330DataRank · unranked
8 citations

Brian A. Gordon, Nicolas R. Barthélemy, Kanta Horie, Rachel L. Henson, Yingxin He +7 more

CSF tau phosphorylation at T217 and T205 are improved biomarkers of amyloid and tau pathology in Alzheimer disease

Research Square(2022)10.21203/rs.3.rs-2175929/v1
N/A
0.165DataRank · unranked
2 citations

Benjamin Saef, Yan Li, Brian A. Gordon, Yingxin He, Kanta Horie +14 more

Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer’s disease

Brain Communications(2024)10.1093/braincomms/fcae247
N/A
0DataRank · unranked
13 citations

Yingxin He, Nicolas R. Barthélemy, Hong Jiang, David M. Holtzman, Randall J. Bateman +1 more

Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers

Alzheimer s & Dementia(2023)10.1002/alz.12930
N/A
0DataRank · unranked
77 citations

Nicolas R. Barthélemy, Vitaliy Ovod, James G. Bollinger, Yingxin He, Samir L. Chahin +4 more